![Man in blue button down shirt poses outside for a picture with his arms crossed.](/sites/default/files/styles/featured_square_large/public/2024-07/Troy_Carter_headshot.jpeg?h=8a7fc05e&itok=VFmZIzHo)
Carter to lead Fusion Energy Division at Oak Ridge National Laboratory
Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Scientists at ORNL have confirmed that bacteria-killing viruses called bacteriophages deploy a sneaky tactic when targeting their hosts: They use a standard genetic code when invading bacteria, then switch to an alternate code at later stages of